Reassortment of Ancient Neuraminidase and Recent Hemagglutinin in Pandemic (H1N1) 2009 Virus by Bhoumik, Priyasma & Hughes, Austin L.
Reassortment   
of Ancient 
Neuraminidase   
and Recent   
Hemagglutinin in   
Pandemic (H1N1) 
2009 Virus
Priyasma Bhoumik and Austin L. Hughes
Sequence  analyses  show  that  the  outbreak  of  pan-
demic (H1N1) 2009 resulted from the spread of a recently 
derived hemagglutinin through a population of ancient and 
more diverse neuraminidase segments. This pattern implies 
reassortment and suggests that the novel form of hemag-
glutinin conferred a selective advantage.
I
nfluenza virus A is a single-strand, negative-sense RNA 
virus whose genome consists of 8 RNA segments that 
encode 10 proteins (1). Influenza A is endemic in wild 
waterfowl, from which new strains periodically emerge to 
infect mammals, including humans and domestic pigs (2). 
Strains of influenza A viruses are categorized according to 
serotypes for hemagglutinin (HA) and neuraminidase (NA) 
proteins. These proteins cover the surface of the virus, are 
the main targets of the host’s cellular immune response, 
and play major roles in the infection process (1,3,4).
In 2009, a novel strain of influenza A virus, pandemic 
(H1N1) 2009 virus, appeared in the human population, in-
fecting thousands and causing many deaths (2,5–8). Phy-
logenetic analyses support a close relationship between the 
new strain and the strains that infect swine (6–9). Because 
different segments of the pandemic (H1N1) 2009 virus ge-
nome show different patterns of relationship to previously 
identified clades of influenza A virus sequences, these analy-
ses support a role for intersegment reassortment in the ori-
gin of the new strain (6–9). For example, HA of pandemic 
(H1N1) 2009 virus shows a close relationship to that of clas-
sical swine influenza A virus, and NA shows a close relation-
ship to that of Eurasian swine influenza A virus (6–9).
The Study
To examine the effects of intersegment reassortment 
on sequence diversity, we analyzed the pattern of nucle-
otide  substitutions  in  pandemic  (H1N1)  2009  virus  and 
compared it with that of other influenza A virus genotypes 
(see www.biol.sc.edu/~austin). In pandemic (H1N1) 2009 
virus,  synonymous  (πS)  and  nonsynonymous  (πN)  nucle-
otide diversity (online Technical Appendix, www.cdc.gov/
EID/content/16/11/1748-Techapp.pdf)  was  significantly 
greater in NA than in HA (Table 1). In pandemic (H1N1) 
2009 virus, πS in NA was >100× that in HA, and πN in NA 
was >50× times that in HA (Table 1). By contrast, in pre-
2009 influenza virus subtype H1N1, πS and πN were simi-
lar in HA and NA (Table 1). Likewise, in influenza virus 
subtypes H3N2 and H5N1, πS and πN were similar in HA 
and NA (Table 1). Thus, pandemic (H1N1) 2009 virus was 
unique among serotypes in showing a marked difference in 
sequence diversity between HA and NA.
To test whether the difference between HA and NA in 
pandemic (H1N1) 2009 virus resulted from sampling er-
ror, we applied the same analysis to 92 epidemiologically 
matched pairs of HA and NA sequences from pandemic 
(H1N1)  2009  virus  (see  www.biol.sc.edu/~austin)  col-
lected in the same month (the same date, when possible) 
and from the same state (or the same country if not of US 
origin). πS was significantly greater in NA (mean ± SE 
0.2537 ± 0.0183) than in HA (0.0030 ± 0.0011; p<0.001 by 
z-test). Likewise, in epidemiologically matched pairs, πN 
was significantly greater in NA (0.0215 ± 0.0022) than in 
HA (0.0012 ± 0.0003; p<0.001 by z-test).
In HA and NA genes of serotypes of influenza sub-
types  H1N1  (pre-2009),  H3N2,  and  H5N1,  πS  was  sig-
nificantly greater than πN (Table 1). For pandemic (H1N1) 
2009, πS was significantly greater than πN in NA (Table 1); 
πS was also greater than πN in HA, but the difference was 
not significant because diversity was low at synonymous 
and nonsynonymous sites (Table 1). πS was significantly 
greater than πN for each of the other 6 genes (online Techni-
cal Appendix Table). A pattern of πS greater than πN indi-
cates past purifying selection that has eliminated deleteri-
ous nonsynonymous mutations (10).
To obtain evidence regarding slightly deleterious vari-
ants  subject  to  ongoing  purifying  selection  (11–13),  we 
examined gene diversity at synonymous and nonsynony-
mous polymorphic single-nucleotide polymorphism (SNP) 
sites in HA and NA genes (Table 2). In the NA genes of 
pandemic (H1N1) 2009 virus, subtypes H1N1 (pre-2009), 
H3N2, and H5N1, the gene diversity at nonsynonymous 
SNP sites was significantly lower than that at synonymous 
SNP sites (Table 2). The same pattern was seen in SNP sites 
in the HA gene of all serotypes except pandemic (H1N1) 
2009 virus. Thus, the HA gene of pandemic (H1N1) 2009 
virus showed a unique pattern in the absence of evidence 
of ongoing purifying selection decreasing the frequency of 
slightly deleterious variants.
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At 9 aa positions in HA, a residue not seen in our sam-
ple of pre-2009 influenza (H1N1) virus was fixed (100% 
frequency) in our sample of pandemic (H1N1) 2009 virus 
(Figure). The following amino acid replacements were in-
volved; residue(s) in pre-2009 influenza (H1N1) are listed 
first:  F/I/L88S,  N101S,  T256K,  N/S275E,  A/D/G277N, 
Q382L, G/R391E, F454Y, and S510A. Of these positions, 
4 (88, 101, 275, and 391) were among those listed as hav-
ing unique amino acid residues in pandemic (H1N1) 2009 
virus on the basis of a smaller sequence sample by Ding et 
al. (9).
Conclusions
Analysis of nucleotide sequences of HA and NA from 
4 serotypes of influenza A virus showed a unique pattern of 
polymorphism in pandemic (H1N1) 2009 virus. In other se-
rotypes, diversity of synonymous and nonsynonymous nu-
cleotides was similar in HA and NA; in pandemic (H1N1) 
2009 virus, HA showed much lower nucleotide diversity 
at synonymous and nonsynonymous sites than did NA. Of 
all serotypes analyzed, NA showed evidence of past and 
ongoing purifying selection against deleterious nonsynony-
mous mutations, and HA showed evidence of past and on-
going purifying selection of all serotypes except pandemic 
(H1N1) 2009 virus. These unique features of HA of pan-
demic (H1N1) 2009 virus imply that it has a more recent 
common ancestor than NA of the same serotype and that 
it has spread rapidly by frequent reassortment into a back-
ground of a much more ancient NA genotype.
The recent spread of HA of pandemic (H1N1) 2009 
virus implies multiple events of reassortment, creating a 
population of viruses with an ancient and diverse NA gene 
and a much less diverse HA gene. The polymerase basic 
protein 1 gene also showed low diversity (online Technical 
Appendix Table), suggesting similar reassortment. Other 
genes of pandemic (H1N1) 2009 virus showed a level of 
diversity intermediate between that of HA and NA, sug-
gesting that their association with this ancient and diverse 
NA may have resulted from earlier reassortment events. 
The bottleneck in the history of HA of pandemic (H1N1) 
2009 virus explains the low genetic diversity and the ab-
sence of evidence of ongoing purifying selection because 
purifying selection is most effective when the population 
is large (11–13). Absence of ongoing purifying selection 
is thus consistent with a recent population expansion, of 
which pandemic (H1N1) 2009 virus shows evidence (14).
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sequences ʌS ± SE  ʌN ± SE 
No.
sequences ʌS ± SE  ʌN ± SE 
Pandemic H1N1 (2009)  397 0.0041 ± 0.0015  0.0012 ± 0.0003  171 0.4626 ± 0.0493†  0.0616 ± 0.0065† 
H1N1 (pre-2009)  105 0.0926 ± 0.0063  0.0171 ± 0.0017  105 0.0842 ± 0.0088  0.0126 ± 0.0016 
H3N2  562 0.1178 ± 0.0094  0.0229 ± 0.0028  357 0.0871 ± 0.0077  0.0213 ± 0.0020 
H5N1  109 0.0918 ± 0.0080  0.0189 ± 0.0026  116 0.1034 ± 0.0082  0.0194 ± 0.0027 
*HA, hemagglutinin; NA, neuraminidase; ʌS, synonymous nucleotide diversity; ʌN, nonsynonymous nucleotide diversity. There was a significant difference 
(p<0.001) between ʌS and ʌN in all cases except HA of pandemic (H1N1) 2009. 
†Significant difference between ʌS or ʌN in NA and corresponding value in HA (z-test; p<0.001). 
Table 2. Mean ± SE gene diversity at synonymous and nonsynonymous polymorphic nucleotide sites in hemagglutinin and 
neuraminidase genes of influenza A virus serotypes* 
Genotype 
HA NA
Synonymous  Nonsynonymous  Synonymous  Nonsynonymous 
Pandemic H1N1 (2009)  0.0120 ± 0.0007 [173]  0.0112 ± 0.0006 [839]  0.2535 ± 0.0173 [179]  0.0863 ± 0.0060 [706]† 
H1N1 (pre-2009)  0.0798 ± 0.0063 [198]  0.0506 ± 0.0019 [814]†  0.0765 ± 0.0083 [152]  0.0453 ± 0.0017 [712]† 
H3N2  0.0710 ± 0.0086 [203]  0.0331 ± 0.0030 [793]†  0.0760 ± 0.0087 [177]  0.0332 ± 0.0029 [688]† 
H5N1  0.1195 ± 0.0106 [184]  0.0552 ± 0.0027 [834]†  0.1120 ± 0.0098 [157]  0.0482 ± 0.0024 [645]† 
*HA, hemagglutinin; NA, neuraminidase. Numbers of polymorphic nucleotide sites are indicated in brackets. 
†Gene diversity at nonsynonymous sites significantly different from that at synonymous sites (p<0.001; randomization test). 
Figure. Structure of the pandemic (H1N1) 2009 virus hemagglutinin 
homotrimer, indicating (in red) the 9 aa positions in hemagglutinin 
at which a residue not found in pre-2009 influenza (H1N1) was 
fixed (100% frequency) in pandemic (H1N1) 2009 virus.One factor that might have favored the spread of a re-
cently evolved HA segment in the pandemic (H1N1) 2009 
virus population would be the occurrence of >1 selectively 
favored aa replacements, causing a selective sweep (15) 
and reducing diversity at the HA locus. Such replacements 
in the ancestor of pandemic (H1N1) 2009 virus would like-
ly be conserved in the pandemic (H1N1) 2009 virus popu-
lation. The 9 aa residues in HA not found in our sample 
of pre-2009 influenza (H1N1), but fixed in our sample of 
pandemic (H1N1) 2009 virus, are candidates for selective-
ly favored amino acid replacements in pandemic (H1N1) 
2009 virus. Low diversity in >1 genes may be a recurring 
feature of newly emerged influenza A pandemics, support-
ing the need for vaccine development early in a pandemic 
to minimize mutation accumulation in viral genes of low 
initial variability.
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